Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have been diagnosed with paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes) and whose doctor has recommended a procedure called catheter ablation, according to specific medical guidelines
- People who have had an episode of atrial fibrillation recorded on a heart tracing (ECG) within the last 12 months
- People who are able to read and sign a consent form agreeing to take part
- Women who could become pregnant must have a negative pregnancy blood test and be using effective contraception
- People who are covered by the French social security system or are otherwise entitled to it
Who may not be able to join:
- People whose atrial fibrillation does not come and go (i.e., it is persistent or permanent rather than paroxysmal)
- People who cannot take blood-thinning medication (anticoagulants)
- People who have a blood clot inside their heart
- People who have previously had an ablation procedure on the left side of their heart
- People who have previously had heart surgery
- People who have moderate or severe disease affecting any of the heart valves (mitral, aortic, or tricuspid valves)
- People who cannot have an MRI scan or cannot receive the contrast dye called DOTAREM™ — this includes people with pacemakers, defibrillators, certain metal implants or devices in the body, severe kidney disease, a known allergy to the contrast agent, or severe claustrophobia (confirm full list of affected devices with trial site)
- People receiving AME (French state medical aid)
- People who are pregnant or breastfeeding
- People who are under legal protection, such as guardianship, or who are not free to make their own decisions
- People who are currently taking part in another interventional clinical study, or who are within a required waiting period after a previous study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marine CAMUS, Assistance Publique - Hôpitaux de Paris
Phone: +33184827620
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference between baseline (pre-ablation) and post-ablation in the amount of left atrial fibrosis such as quantified by 3D late gadolinium enhancement (g, %) (related to primary objective) (MRI measurement)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.